Compare DPZ & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DPZ | ASND |
|---|---|---|
| Founded | 1960 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 13.6B |
| IPO Year | 2004 | 2014 |
| Metric | DPZ | ASND |
|---|---|---|
| Price | $395.00 | $230.34 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 24 | 15 |
| Target Price | ★ $473.25 | $278.80 |
| AVG Volume (30 Days) | ★ 931.8K | 713.8K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.76% | N/A |
| EPS Growth | ★ 5.27 | N/A |
| EPS | ★ 17.57 | N/A |
| Revenue | ★ $4,939,994,000.00 | N/A |
| Revenue This Year | $8.14 | $98.02 |
| Revenue Next Year | $4.01 | $43.13 |
| P/E Ratio | $22.53 | ★ N/A |
| Revenue Growth | ★ 4.96 | N/A |
| 52 Week Low | $370.70 | $124.06 |
| 52 Week High | $499.08 | $248.60 |
| Indicator | DPZ | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 46.87 | 49.46 |
| Support Level | $376.59 | $190.49 |
| Resistance Level | $421.93 | $245.30 |
| Average True Range (ATR) | 11.55 | 9.40 |
| MACD | 0.10 | -0.89 |
| Stochastic Oscillator | 23.20 | 35.92 |
Domino's is a restaurant operator and franchiser with over 21,500 global stores across more than 90 international markets at the end of the second quarter of 2025. The firm generates revenue through the sales of pizza, wings, salads, sandwiches, and desserts at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's US and Canadian restaurants. With roughly $19.2 billion in 2024 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Little Caesars, and Papa John's.
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.